GERON CORP Increase (Decrease) in Restricted Cash
GERON CORP (GERN) reported Increase (Decrease) in Restricted Cash of $1.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-16
- GERON CORP increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- GERON CORP increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $1.00K.
- GERON CORP increase (decrease) in restricted cash for the quarter ending 2013-12-31 was $0.00.
- GERON CORP increase (decrease) in restricted cash for the quarter ending 2013-09-30 was $0.00.
- GERON CORP increase (decrease) in restricted cash for fiscal 2016 was $1.00K, a 0.00% change from fiscal 2015.
- GERON CORP increase (decrease) in restricted cash for fiscal 2015 was $1.00K.
- GERON CORP increase (decrease) in restricted cash for fiscal 2014 was -$529.00K, a 53000.00% decline from fiscal 2013.
- GERON CORP increase (decrease) in restricted cash for fiscal 2013 was $1.00K, a 0.00% change from fiscal 2012.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.00K 10-K · filed 2018-03-16 | ||
| 2016-09-30 | $1.00K 10-Q · filed 2017-11-01 | |||
| 2015-12-31 | $1.00K 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$529.00K 10-K · filed 2017-03-01 | ||
| 2014-09-30 | -$530.00K 10-Q · filed 2015-11-05 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $0.00 derived: sum of 2 quarters · filed 2016-03-10 | $1.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $1.00K 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $1.00K 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $1.00K 10-K · filed 2015-03-11 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $1.00K 10-Q · filed 2013-08-08 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $1.00K 10-K · filed 2014-03-17 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.00K 10-Q · filed 2012-11-02 | ||
| 2011-06-30 | $1.00K 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $1.00K 10-K · filed 2013-03-15 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $1.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $1.00K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$25.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |